Search Results - "YANG, TIANBING"

Refine Results
  1. 1
  2. 2

    Human corneal stromal stem cells express anti-fibrotic microRNA-29a and 381-5p – A robust cell selection tool for stem cell therapy of corneal scarring by Yam, Gary Hin-Fai, Yang, Tianbing, Geary, Moira L, Santra, Mithun, Funderburgh, Martha, Rubin, Elizabeth, Du, Yiqin, Sahel, Jose A, Jhanji, Vishal, Funderburgh, James L

    Published in Journal of advanced research (01-03-2023)
    “…A schematic overview of this study showing corneal stromal stem cell (CSSC) isolation from anterior limbal stromal tissue, ex vivo cell culture, extraction of…”
    Get full text
    Journal Article
  3. 3

    Pericytes reduce inflammation and collagen deposition in acute wounds by BODNAR, RICHARD J, YANG, TIANBING, RIGATTI, LORA H, LIU, FANG, EVDOKIOU, ALEXANDER, KATHJU, SANDEEP, SATISH, LATHA

    Published in Cytotherapy (Oxford, England) (01-08-2018)
    “…Abstract Background Pericytes have been shown to have mesenchymal stromal cell–like properties and play a role in tissue regeneration. The goal of this study…”
    Get full text
    Journal Article
  4. 4

    The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor β3 by Weng, Lin, Funderburgh, James L., Khandaker, Irona, Geary, Moira L., Yang, Tianbing, Basu, Rohan, Funderburgh, Martha L., Du, Yiqin, Yam, Gary Hin-Fai

    Published in Eye and vision (Novato, Calif.) (03-11-2020)
    “…Abstract Background Corneal stromal stem cells (CSSC) reduce corneal inflammation, prevent fibrotic scarring, and regenerate transparent stromal tissue in…”
    Get full text
    Journal Article
  5. 5

    Induction of CCL20 production by Kaposi sarcoma–associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-κB activation by Punj, Vasu, Matta, Hittu, Schamus, Sandra, Yang, Tianbing, Chang, Yuan, Chaudhary, Preet M.

    Published in Blood (28-05-2009)
    “…Kaposi sarcoma–associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sarcoma (KS), an angioproliferative lesion…”
    Get full text
    Journal Article
  6. 6

    K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 expression: a model of lytic replication induced clonal selection in viral oncogenesis by Zhao, Jinshun, Punj, Vasu, Matta, Hittu, Mazzacurati, Lucia, Schamus, Sandra, Yang, Yanqiang, Yang, Tianbing, Hong, Yan, Chaudhary, Preethello M

    Published in PloS one (24-10-2007)
    “…Accumulating evidence suggests that dysregulated expression of lytic genes plays an important role in KSHV (Kaposi's sarcoma associated herpesvirus)…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Cyclooxygenase-2 Inhibition for the Prevention of Subglottic Stenosis by Cetin, Selma, Tobey, Allison B, Sandulache, Vlad C, Yang, Tianbing, Barsic, Mark, Lin, Yan, Dohar, Joseph E, Hebda, Patricia A

    “…OBJECTIVE To evaluate the role of targeted cyclooxygenase-2 inhibition in reducing scarring associated with a subglottic airway mucosal injury. DESIGN…”
    Get full text
    Journal Article
  9. 9

    Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IκB Kinase Complex to Selectively Activate NF-κB without JNK Activation by Matta, Hittu, Mazzacurati, Lucia, Schamus, Sandra, Yang, Tianbing, Sun, Qinmiao, Chaudhary, Preet M.

    Published in The Journal of biological chemistry (24-08-2007)
    “…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-κB and plays a key role in viral pathogenesis. K13 contains a putative…”
    Get full text
    Journal Article
  10. 10

    The anti-scarring effect of corneal stromal stem cell therapy is mediated by transforming growth factor [beta]3 by Weng, Lin, Funderburgh, James L, Khandaker, Irona, Geary, Moira L, Yang, Tianbing, Basu, Rohan, Funderburgh, Martha L, Du, Yiqin, Yam, Gary Hin-Fai

    Published in Eye and vision (Novato, Calif.) (03-11-2020)
    “…Background Corneal stromal stem cells (CSSC) reduce corneal inflammation, prevent fibrotic scarring, and regenerate transparent stromal tissue in injured…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Phase I and pharmacokinetic study of dasatinib and cetuximab in patients with advanced solid malignancies by Argiris, Athanassios, Feinstein, Trevor M., Wang, Lin, Yang, Tianbing, Agrawal, Shruti, Appleman, Leonard J., Stoller, Ronald G., Grandis, Jennifer R., Egloff, Ann Marie

    Published in Investigational new drugs (01-08-2012)
    “…Summary Background Combined inhibition of epidermal growth factor receptor (EGFR) and Src family kinases (SFK) may lead to improved therapeutic effects. We…”
    Get full text
    Journal Article
  13. 13

    Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IκB Kinase Complex to Selectively Activate NF-κB without JNK Activation by Hittu Matta, Lucia Mazzacurati, Sandra Schamus, Tianbing Yang, Qinmiao Sun, Preet M. Chaudhary

    Published in The Journal of biological chemistry (24-08-2007)
    “…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-κB and plays a key role in viral pathogenesis. K13 contains a putative…”
    Get full text
    Journal Article
  14. 14

    Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation by Matta, Hittu, Mazzacurati, Lucia, Schamus, Sandra, Yang, Tianbing, Sun, Qinmiao, Chaudhary, Preet M

    Published in The Journal of biological chemistry (24-08-2007)
    “…Kaposi's sarcoma herpesvirus oncoprotein vFLIP K13 is a potent activator of NF-kappaB and plays a key role in viral pathogenesis. K13 contains a putative…”
    Get full text
    Journal Article
  15. 15
  16. 16

    CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture by Yang, Tianbing, Flint, Melanie S, Webb, Katie M, Chambers, William H

    Published in Immunologic research (01-01-2006)
    “…Co-culture of natural killer (NK) cells and dendritic cells (DCs) results in their reciprocal co-activation, and an enhancement of lysis of tumor target cells…”
    Get full text
    Journal Article
  17. 17

    Expression of a soluble transforming growth factor-[beta] (TGF[beta]) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo by Witham, Timothy F, Villa, Lorissa, Yang, Tianbing, Pollack, Ian F

    Published in Journal of neuro-oncology (01-08-2003)
    “…Immunotherapy of gliomas has been forwarded as an attractive alternative to standard therapeutic modalities. Numerous observations indicate some therapeutic…”
    Get full text
    Journal Article
  18. 18

    Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo by Witham, Timothy F, Villa, Lorissa, Yang, Tianbing, Pollack, Ian F, Okada, Hideho, Robbins, Paul D, Chambers, William H

    Published in Journal of neuro-oncology (01-08-2003)
    “…Immunotherapy of gliomas has been forwarded as an attractive alternative to standard therapeutic modalities. Numerous observations indicate some therapeutic…”
    Get full text
    Journal Article
  19. 19

    Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation by Punj, Vasu, Matta, Hittu, Schamus, Sandra, Yang, Tianbing, Chang, Yuan, Chaudhary, Preet M

    Published in Blood (28-05-2009)
    “…Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8, is the etiologic agent of Kaposi sarcoma (KS), an angioproliferative lesion…”
    Get full text
    Journal Article
  20. 20